INGN Stock Analysis: Buy, Sell, or Hold?
INGN - Inogen Inc
$5.90
0.08 (1.37%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 24, 2026
23d
Get Alerted When INGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: INGN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: INGN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: INGN is currently trading at $5.90, which is considered oversold relative to its 30-day fair value range of $6.05 to $6.86.
Technical Outlook: Technically, INGN is in a strong downtrend. Immediate support is located at $5.69, while resistance sits at $6.47.
Market Sentiment: INGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (29th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.00 (+123.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INGN is in a strong downtrend. Immediate support is located at $5.69, while resistance sits at $6.47.
Market Sentiment: INGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (29th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.00 (+123.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$6.05 -
$6.86
Company Quality Score
56/100
(HOLD)
Options IV Signal
29th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 29th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 123.4% below Wall St target ($13.00)
Fair Price Analysis
30-Day Fair Range
$6.05 -
$6.86
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.55
(9.4%)
Support & Resistance Levels
Support Level
$5.69
Resistance Level
$6.47
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-36.38
Wall Street Target
$13.00
(+123.4%)
Revenue Growth (YoY)
4.0%
Earnings Growth (YoY)
87.3%
Profit Margin
-7.3%
Last updated: January 31, 2026 11:20 AM ET
Data refreshes hourly during market hours. Next update: 12:19 PM
Data refreshes hourly during market hours. Next update: 12:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
Advanced INGN Option Strategies
Professional options setups generated by AI based on today's INGN price and gamma walls.
